Divergent Peptides for Hydroxylapatite Binding
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current peptide technologies for binding with hydroxylapatite have limited affinity due to one-dimensional interaction, which restricts their effectiveness in biomineral applications, such as bone and dental treatments, as they fail to fully utilize the calcium and phosphate ions on the hydroxylapatite surface.
Innovation Solution
Development of divergent peptides with two- or three-dimensional configurations using polyamindoamine and polylysine dendrimer frameworks, conjugated with aspartic acid, to enhance binding affinity through multivalent interactions and cluster effects, providing a more stable and effective mineral binding mechanism.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If linear peptide structures with 6-12 aspartic acids are used, then calcium binding affinity is achieved, but binding strength is limited due to one-dimensional interaction
Solution Approach 1:
The patent transitions from linear one-dimensional peptide structures to two-dimensional and three-dimensional dendritic structures. The dendrimers incorporate aspartic acid residues arranged in radial patterns extending from a core, creating multiple binding planes that can simultaneously interact with calcium ions on the hydroxylapatite surface, thereby significantly enhancing binding strength beyond what linear peptides can achieve.
Solution Approach 2:
The patent divides the peptide chain into multiple independent branches radiating from a central core in dendritic structures. Each branch contains aspartic acid residues that can independently bind calcium ions, allowing the overall structure to engage multiple calcium binding sites on the hydroxylapatite surface simultaneously, thus improving overall binding affinity and strength.
2Adaptability or versatility
If polyaspartic acid sequences are used, then mineral binding capability is provided, but interaction dimensionality remains limited to one-dimensional linear arrangement
Solution Approach 1:
The patent incorporates polyaspartic acid sequences into dendritic architectures where multiple polyaspartic acid chains radiate from a central core in two-dimensional or three-dimensional arrangements. This maintains the mineral binding capability of polyaspartic acid while dramatically increasing the spatial dimensionality of interaction, allowing simultaneous engagement of multiple calcium and phosphate sites on hydroxylapatite surfaces.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The divergent peptides demonstrate improved binding ability with hydroxylapatite, as evidenced by increased retention times in chromatography tests, indicating stronger mineral affinity and potential for enhanced biomineral applications in drug delivery, gene therapy, and medical imaging.
Implementation Method 1
a molecule whose possess affinity with biomineral, in general, it must has a basic structure to provide calcium binding such as polycarboxylic acid or polyphosphoric acid
Implementation Method 2
polyaspartic acid is usually to be used as an osteophilic reagent to simulate the natural protein which is rich in aspartic acid
Implementation Method 3
Development of divergent peptides with two- or three-dimensional configurations using polyamindoamine and polylysine dendrimer frameworks, conjugated with aspartic acid, to enhance binding affinity through multivalent interactions and cluster effects
Implementation Method 4
The divergent peptides demonstrate improved binding ability with hydroxylapatite, as evidenced by increased retention times in chromatography tests, indicating stronger mineral affinity
Data Source
AI summary
A series of peptides with divergent confirmations including structures of formula (1A), (1B), (2) and (3) are provided. In the formula, wherein U, G, A, B, R1, R2 and T are as defined in the specification. The divergent peptides disclosed in the present invention are characterized in a mineral binding affinity function.